These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 736736

  • 1. [Preventive treatment with theophylline of apnea in premature infants: clinical, pharmokinetic and neurophysiological study].
    Demarquez JL, Brachet-Lierman A, Paty J, Deliac MM, Philippe JC, Maix M, Babin JP, Martin C.
    Arch Fr Pediatr; 1978; 35(7):793-805. PubMed ID: 736736
    [Abstract] [Full Text] [Related]

  • 2. [Therapeutic concentrations of theophylline and caffeine during treatment of apnea in premature infants with theophylline].
    Alix D, Berthou F, Riche C, Gouedard H.
    Arch Fr Pediatr; 1985; 42(6):465-9. PubMed ID: 4051680
    [Abstract] [Full Text] [Related]

  • 3. Caffeine versus theophylline for apnea of prematurity: a randomised controlled trial.
    Skouroliakou M, Bacopoulou F, Markantonis SL.
    J Paediatr Child Health; 2009 Oct; 45(10):587-92. PubMed ID: 19751376
    [Abstract] [Full Text] [Related]

  • 4. [Pharmacokinetics of theophylline in low birth weight newborn infants].
    Cottancin G, Baltassat P, Bory C, Challamel MJ, Frederich A.
    Pediatrie; 1977 Oct; 32(7):677-84. PubMed ID: 928035
    [No Abstract] [Full Text] [Related]

  • 5. [Apnea and theophylline in the premature infant. Clinical and pharmacokinetic study in 32 premature infants].
    Cottancin G, Sann L, Bory B, Bourgeois J, Frederich A, Baltassat P, Bethenod M.
    Pediatrie; 1981 Mar; 36(2):91-101. PubMed ID: 7232073
    [No Abstract] [Full Text] [Related]

  • 6. Prevention of apnea and bradycardia in low-birthweight infants.
    Shannon DC, Gotay F, Stein IM, Rogers MC, Todres ID, Moylan FM.
    Pediatrics; 1975 May; 55(5):589-94. PubMed ID: 236535
    [Abstract] [Full Text] [Related]

  • 7. Accuracy and reliability of dosing equations to individualize theophylline treatment of apnea of prematurity.
    Bhatt-Mehta V, Johnson CE, Donn SM, Spadoni V, Schork MA.
    Pharmacotherapy; 1995 May; 15(2):246-50. PubMed ID: 7624272
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Factors affecting theophylline pharmacokinetics in premature infants with apnea.
    Hilligoss DM, Jusko WJ, Koup JR, Giacoia G.
    Dev Pharmacol Ther; 1980 May; 1(1):6-15. PubMed ID: 7438966
    [Abstract] [Full Text] [Related]

  • 12. Developmental outcome of premature infants treated with theophylline.
    Nelson RM, Resnick MB, Holstrum WJ, Eitzman DV.
    Dev Pharmacol Ther; 1980 May; 1(5):274-80. PubMed ID: 7438973
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Plasma concentration-effect relationship of theophylline in treatment of apnea in preterm infants.
    Lagercrantz H, Rane A, Tunell R.
    Eur J Clin Pharmacol; 1980 Jul; 18(1):65-8. PubMed ID: 7398750
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Methylxanthines in apnea of prematurity.
    Aranda JV, Turmen T.
    Clin Perinatol; 1979 Mar; 6(1):87-108. PubMed ID: 383366
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.